Philip Morris International (NYSE:PM) brought new evidence before the FDA's tobacco advisory committee to support keeping its ...
SILVER SPRING, Md. — Philip Morris International Inc. (PMI) made its case to continue to market its heat-not-burn IQOS as a ...
11don MSN
Philip Morris International seeks FDA approval to keep marketing IQOS as reduced risk product
The FDA granted the MRTP designation to the IQOS system in 2020 for an initial four-year period. The evidence presented to ...
Philip Morris International claims to be ending smoking for good. Science, money, and controversy are shaping its smoke-free ...
Italy's antitrust regulator said on Wednesday it had opened an investigation into Philip Morris Italia for alleged unfair ...
International presented evidence to the Tobacco Products Scientific Advisory Committee. The committee, comprised of independent scientific researchers, provides nonbinding recommendations to the U.S.
Companies with a long history of paying dividends and consistently hiking them remain appealing to income-focused investors.
Philip Morris's unwavering commitment to income generation reached a new milestone in September 2025 when the company ...
Asianet Newsable on MSN
Philip Morris Seeks FDA Approval To Keep IQOS Modified Risk Designation For Later Versions Of Device
The modified risk tobacco product designation granted by the FDA initially in 2020 allowed the company to advertise IQOS’ ...
Philip Morris International Inc. (NYSE:PM) manufactures and sells cigarettes and smoke-free products, including IQOS and ZYN ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback